EMR files Form 144 to sell 4,773 shares valued at 640,000
EMR has a planned insider sale under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
EMR has a planned insider sale under Rule 144. The notice covers the proposed sale of 4,773 shares of common stock, with an aggregate market value of 640,000. These shares are part of 1,500,000 shares outstanding and are to be sold through Merrill Lynch on or about 12/01/2025 on the NYSE. The seller originally acquired the shares on 02/01/2016 as a stock award from the issuer, described as compensation.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does EMR's latest Form 144 filing disclose?
What does the Form 144 representation say about material information for EMR?
AI-generated analysis. How Rhea-AI works. Not financial advice.